Spok Holdings, Inc.
NASDAQ:SPOKMedical - Healthcare Information Services
+$0.17 today
- Market cap
- $228.30M
- Beta
- 0.44
- P/E (TTM)
- 17.2
- EPS (TTM)
- $0.61
- Dividend yield
- 11.93%
Volume 0.18M
Average 0.17M
SPOK Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Spok Holdings, Inc.NASDAQ: SPOK
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development growth accelerates
Q1 FY2026 research & development of $3.46M rose 13.2% year over year, ahead of the +7.2% change in trailing-twelve-month research & development. Sequentially, it rose 14.4% from the prior quarter. Over 3 fiscal years it compounded at -3.9% a year.
Context
- Research & development amounted to 8.7% of revenue in FY2025, up 0.3 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +13.2% holds above the trailing-twelve-month pace of +7.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 12.09M USD
- Year-over-year change
- +4.7%
- 4-year CAGR
- -9.4%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 12.09M | +4.7% |
| FY2024 | 2024-12-31 | 11.55M | +9.5% |
| FY2023 | 2023-12-31 | 10.55M | -22.6% |
| FY2022 | 2022-12-31 | 13.63M | -24.0% |
| FY2021 | 2021-12-31 | 17.92M | — |
Research & Development vs competitors
How SPOK compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +7.2% is the 4th highest of 10, against a peer median of -10.1%.
- Research & development amounts to 9.1% of revenue for SPOK, versus a peer median of 12.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $65.65M USD | +7.6% | +0.8% | 29.5% | |
| LTM Mar 2026 | $39.88M USD | +24.6% | +1.7% | 11.5% | |
| LTM Mar 2026 | $35.89M USD | +5.3% | -1.7% | 44.2% | |
| LTM Mar 2026 | $32.9M USD | -13.4% | -7.3% | 80.8% | |
| LTM Mar 2026 | $31.97M USD | -10.4% | -0.1% | 13.4% | |
| LTM Mar 2026 | $13.97M USD | -23.1% | -7.7% | 24.2% | |
| LTM Mar 2026 | $12.5M USD | +7.2% | -3.9% | 9.1% | |
| LTM Feb 2026 | $9.34M USD | +29.5% | +29.0% | 11.6% | |
| LTM Mar 2026 | $2.8M USD | -10.1% | +3.8% | 1.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | CA$0 CAD | -100.0% | — | 0.0% | |
| Peer median (excluding SPOK) | — | -10.1% | +0.4% | 12.5% | |
Competitors are the stored peer set for SPOK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 142.15M | 134.53M | 139.03M | 137.65M | 139.71M |
| Cost of Revenue | 72.27M | 59.25M | 57.16M | 28.43M | 29.57M |
| Gross Profit | 69.89M | 75.28M | 81.87M | 109.22M | 110.14M |
| Gross Margin | 49.2% | 56.0% | 58.9% | 79.3% | 78.8% |
| Research & Development | 17.92M | 13.63M | 10.55M | 11.55M | 12.09M |
| Selling, General & Admin | 64.02M | 54.09M | 49.52M | 49.15M | 50.87M |
| Operating Expenses | 81.94M | 67.72M | 60.07M | 90.26M | 90.43M |
| Depreciation & Amortization | 10.45M | 3.57M | 4.5M | 4.15M | 3.43M |
| EBITDA | (16.89M) | 4.57M | 26.82M | 24.22M | 24.87M |
| EBITDA Margin | -11.9% | 3.4% | 19.3% | 17.6% | 17.8% |
| Operating Income | (12.06M) | 7.57M | 21.8M | 18.97M | 19.71M |
| Operating Margin | -8.5% | 5.6% | 15.7% | 13.8% | 14.1% |
| Interest Income | 320K | 592K | 1.1M | 1.15M | 820K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (15.28M) | (6.57M) | 524K | 1.07M | 1.73M |
| Income Before Tax | (27.33M) | 997K | 22.33M | 20.03M | 21.44M |
| Pre-Tax Margin | -19.2% | 0.7% | 16.1% | 14.6% | 15.3% |
| Income Tax Expense | (5.15M) | (20.86M) | 6.66M | 5.07M | 5.56M |
| Net Income | (22.18M) | 21.86M | 15.67M | 14.97M | 15.88M |
| Net Margin | -15.6% | 16.2% | 11.3% | 10.9% | 11.4% |
| EPS (Basic) | (1.14) | 1.11 | 0.79 | 0.74 | 0.77 |
| EPS (Diluted) | (1.14) | 1.09 | 0.77 | 0.73 | 0.75 |
| Weighted Avg Shares | 19.4M | 19.67M | 19.95M | 20.24M | 20.61M |
| Weighted Avg Shares (Diluted) | 19.4M | 19.99M | 20.34M | 20.57M | 21.07M |
Spok Holdings, Inc.
NASDAQ:SPOK
Intrinsic Alpha fair value
Locked
Current Price
$10.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.